Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
GlobeNewswire (May 10, 2013)
-
GlobeNewswire (May 7, 2013)
-
GlobeNewswire (Apr 26, 2013)
-
GlobeNewswire (Apr 25, 2013)
-
GlobeNewswire (Apr 15, 2013)
-
GlobeNewswire (Apr 10, 2013)
-
GlobeNewswire (Mar 18, 2013)
To learn more about Seeking Alpha Pro, click here.
-
Novavax Advances Avian Flu Vaccine Despite Government SnubH.S. Ayoub • Wed, Jan 24, 2007
-
Novavax Should Jump On Avian Flu ResultsMicrocap Speculator • Tue, Jan 23, 2007
-
Smallcap Novavax Has Turned a CornerMicrocap Speculator • Tue, Dec 5, 2006
-
Novavax Stuck in DowntrendMicrocap Speculator • Mon, Jul 24, 2006
-
Analyzing Wednesday's Noteworthy Insider TradesGuruFundPicks • Thu, Apr 12, 2012
-
Novavax's CEO Discusses Q3 2012 Results - Earnings Call TranscriptFri, Nov 2, 2012
-
Novavax, Inc. Q3 2008 Earnings Call TranscriptMon, Nov 10, 2008
-
Novavax, Inc. Q2 2008 Earnings Call TranscriptTue, Sep 2, 2008
-
GlobeNewswire (May 10, 2013)
-
GlobeNewswire (May 7, 2013)
-
GlobeNewswire (Apr 26, 2013)
-
GlobeNewswire (Apr 25, 2013)
-
GlobeNewswire (Apr 15, 2013)
-
GlobeNewswire (Apr 10, 2013)
-
GlobeNewswire (Mar 18, 2013)
-
GlobeNewswire (Mar 13, 2013)
-
GlobeNewswire (Mar 8, 2013)
-
GlobeNewswire (Mar 1, 2013)
-
GlobeNewswire (Feb 22, 2013)
-
GlobeNewswire (Feb 7, 2013)
-
GlobeNewswire (Jan 24, 2013)
-
GlobeNewswire (Dec 6, 2012)
-
GlobeNewswire (Dec 3, 2012)
-
GlobeNewswire (Nov 20, 2012)
-
GlobeNewswire (Nov 12, 2012)
-
GlobeNewswire (Nov 2, 2012)
-
GlobeNewswire (Oct 26, 2012)
NVAX vs. ETF Alternatives
Company Description
Novavax, Inc., a Delaware corporation (“Novavax” or the “Company”), was incorporated in 1987, and is a clinical-stage biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. These... More






